Read More Healthcare Industry News Tempus AI stock soars 14% after FDA approval of xT CDx test Tempus AI, a leader in healthcare technology, has unveiled its FDA-approved in vitro diagnostic device, xT CDx, marking… byPallavi MadhirajuJanuary 15, 2025